Ignite Creation Date:
2025-12-24 @ 5:02 PM
Ignite Modification Date:
2026-02-03 @ 4:16 PM
Study NCT ID:
NCT01281150
Status:
COMPLETED
Last Update Posted:
2015-05-25
First Post:
2011-01-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Veliparib in Combination With Carboplatin and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Sponsor:
National Cancer Institute (NCI)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Adult Solid Neoplasm | View |
| None | Estrogen Receptor Negative | View |
| None | Estrogen Receptor Positive | View |
| None | HER2/Neu Negative | View |
| None | Male Breast Carcinoma | View |
| None | Progesterone Receptor Negative | View |
| None | Recurrent Breast Carcinoma | View |
| None | Stage IIIB Breast Cancer | View |
| None | Stage IIIC Breast Cancer | View |
| None | Stage IV Breast Cancer | View |
| None | Triple-Negative Breast Carcinoma | View |
Keywords: